fda import alert glp-1 semaglutide tirzepatide green list Creates to Block Certain Ingredients Used for Compounding GLP-1s FDA's green list cracks down

With advancements in molecular diagnostics, more precise subtyping of triple-negative breast cancer has been achieved, leading to the introduction of new treatment strategies that, when combined with chemotherapy, have significantly improved patient outcomes

an investigational compound, animal-model data only

Layer with hydrating ingredients to maintain balance and comfort

The FDA created a green list alert to flag imported GLP-1 active ingredients that may have quality concerns, the spokesperson said, but they noted that the list does not create new limits on legal compounding of drugs

GHK-Cu ranks among the most anti-cancer compounds tested

Some plans now also cover GLP-1s for weight loss